PBL InterferonSource last week launched its Quansys Q-Plex cytokine multiplex ELISA arrays, high-throughput interferon detection kits that the firm believes will enable drug discovery and clinical research efforts in the treatment of infectious diseases and autoimmunity.
Developed by Quansys Biosciences, the quantitative enzyme-linked immunosorbant assay-based tests contain up to 16 distinct capture antibodies in each well of a 96-well plate. Using the system, up to 84 different samples can be assayed for 16 cytokines in less than two and a half hours, PBL claimed. Current Q-Plex products include six human and four mouse cytokine arrays that are compatible with serum, plasma, cell culture supernatant, homogenates, lysates, nasal lavage, tears, and urine
According to PBL, the Q-Plex kits allow users to assess cytokine profiles at various points throughout the course of disease; correlate cytokine profile alterations with patient responses to therapies; and determine drugs' off-target effects. Later this year, PBL said it will launch human interferon-based multiplex ELISA arrays that can quantify the levels of Type I, II and III human interferons
GeneGo has included access to Sigma-Aldrich life science and chemistry products in its MetaCore 6.0, MetaDrug, and Eureka products. GeneGo said that customers can now retrieve comprehensive information on drugs and compounds and make one-click purchases from one centralized location.